Mateu Espasa

Dr. Mateu Espasa

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in The Lancet
Verified
Journal Article
Closed access
PAPedro L Alonso
Pedro L Alonso
JSJahit Sacarlal
Jahit Sacarlal
JAJohn J Aponte
John J Aponte
ALAmanda Leach
Amanda Leach
EMEusebio Macete
Eusebio Macete
WBW Ripley Ballou
W Ripley Ballou

1 December 2014 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
MGMarian Garcia-Nuñez
Marian Garcia-Nuñez
LMLaura Millares
Laura Millares
XPXAVIER POMARES
XAVIER POMARES
Rafaela G. FerrariRafaela G. Ferrari
Rafaela G. Ferrari
VPVicente Perez
Vicente Perez
EMEduard Monsó
Eduard Monsó
Bronchial colonization by potentially pathogenic microorganisms (PPMs) is often demonstrated in chronic obstructive pulmonary disease (COPD), but culture-based techniques identify only a portion of the bacteria in mucosal surfaces. The aim of the study was to determine changes in the bronchial microbiome of COPD associated with the severity of the disease. The bronchial microbiome of COPD patients was analyzed by 16S rRNA gene amplification and pyrosequencing in sputum samples obtained during stable disease. Seventeen COPD patients were studied (forced expiratory volume in the first second expressed as a percentage of the forced vital capacity [FEV 1 %] median, 35.0%; interquartile range [IQR], 31.5 to 52.0), providing a mean of 4,493 (standard deviation [SD], 2,598) sequences corresponding to 47 operational taxonomic units (OTUs) (SD, 17) at a 97% identity level. Patients were dichotomized according to their lung function as moderate to severe when their FEV 1 % values were over the median and as advanced when FEV 1 % values were lower. The most prevalent phyla in sputum were Proteobacteria (44%) and Firmicutes (16%), followed by Actinobacteria (13%). A greater microbial diversity was found in patients with moderate-to-severe disease, and alpha diversity showed a statistically significant decrease in patients with advanced disease when assessed by Shannon (ρ = 0.528; P = 0.029, Spearman correlation coefficient) and Chao1 (ρ = 0.53; P = 0.028, Spearman correlation coefficient) alpha-diversity indexes. The higher severity that characterizes advanced COPD is paralleled by a decrease in the diversity of the bronchial microbiome, with a loss of part of the resident flora that is replaced by a more restricted microbiota that includes PPMs.

22 January 2014 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
LML. Millares
L. Millares
Rafaela G. FerrariRafaela G. Ferrari
Rafaela G. Ferrari
MGM. Gallego
M. Gallego
MGM. Garcia-Nuñez
M. Garcia-Nuñez
VPVicente Perez
Vicente Perez
EMEduard Monsó
Eduard Monsó
The bronchial microbiome in severe COPD during stability and exacerbation in patients chronically colonised by Pseudomonas aeruginosa (PA), has not been defined. Our objective was to determine the characteristics of the bronchial microbiome of severe COPD patients colonised and not colonised by P. aeruginosa and its changes during exacerbation. COPD patients with severe disease and frequent exacerbations were categorised according to chronic colonisation by P. aeruginosa. Sputum samples were obtained in stability and exacerbation, cultured, and analysed by 16S rRNA gene amplification and pyrosequencing. Sixteen patients were included, 5 of them showing chronic colonisation by P. aeruginosa. Pseudomonas genus had significantly higher relative abundance in stable colonised patients (p = 0.019), but no significant differences in biodiversity parameters were found between the two groups (Shannon, 3 (2–4) vs 3 (2–3), p = 0.699; Chao1, 124 (77–159) vs 140 (115–163), p = 0.364). In PA-colonised patients bronchial microbiome changed to a microbiome similar to non-PA-colonised patients during exacerbations. An increase in the relative abundance over 20 % during exacerbation was found for Streptococcus, Pseudomonas, Moraxella, Haemophilus, Neisseria, Achromobacter and Corynebacterium genera, which include recognised potentially pathogenic microorganisms, in 13 patients colonised and not colonised by P. aeruginosa with paired samples. These increases were not identified by culture in 5 out of 13 participants (38.5 %). Stable COPD patients with severe disease and PA-colonised showed a similar biodiversity to non-PA-colonised patients, with a higher relative abundance of Pseudomonas genus in bronchial secretions. Exacerbation in severe COPD patients showed the same microbial pattern, independently of previous colonisation by P. aeruginosa.

28 April 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DBDany J. V. Beste
Dany J. V. Beste
MEMateu Espasa
Mateu Espasa
BBBhushan Bonde
Bhushan Bonde
AKAndrzej M. Kierzek
Andrzej M. Kierzek
GSGraham R. Stewart
Graham R. Stewart
JMJohnjoe Mcfadden
Johnjoe Mcfadden
Mycobacterium tuberculosis infects a third of the world's population. Primary tuberculosis involving active fast bacterial replication is often followed by asymptomatic latent tuberculosis, which is characterised by slow or non-replicating bacteria. Reactivation of the latent infection involving a switch back to active bacterial replication can lead to post-primary transmissible tuberculosis. Mycobacterial mechanisms involved in slow growth or switching growth rate provide rational targets for the development of new drugs against persistent mycobacterial infection. Using chemostat culture to control growth rate, we screened a transposon mutant library by Transposon site hybridization (TraSH) selection to define the genetic requirements for slow and fast growth of Mycobacterium bovis (BCG) and for the requirements of switching growth rate. We identified 84 genes that are exclusively required for slow growth (69 hours doubling time) and 256 genes required for switching from slow to fast growth. To validate these findings we performed experiments using individual M. tuberculosis and M. bovis BCG knock out mutants. We have demonstrated that growth rate control is a carefully orchestrated process which requires a distinct set of genes encoding several virulence determinants, gene regulators, and metabolic enzymes. The mce1 locus appears to be a component of the switch to slow growth rate, which is consistent with the proposed role in virulence of M. tuberculosis. These results suggest novel perspectives for unravelling the mechanisms involved in the switch between acute and persistent TB infections and provide a means to study aspects of this important phenomenon in vitro.

1 August 2006 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
EMEusebio Macete
Eusebio Macete
PAPedro Aide
Pedro Aide
JAJohn J. Aponte
John J. Aponte
SSSergi Sanz
Sergi Sanz
IMInacio Mandomando
Inacio Mandomando
CMClara Menendez
Clara Menendez
BackgroundThere is an urgent need to deploy and develop new control tools that will reduce the intolerable burden of malaria. Intermittent preventive

26 June 2014 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
MGMiguel Gallego
Miguel Gallego
XPXAVIER POMARES
XAVIER POMARES
MEMateu Espasa
Mateu Espasa
ECEva Castañer
Eva Castañer
MSMar Solé
Mar Solé
CMConcepción Montón
Concepción Montón
Patients with severe chronic obstructive pulmonary disease (COPD) are at increased risk of infection by P. aeruginosa. The specific role of bronchiectasis in both infection and chronic colonization by this microorganism in COPD, however, remains ill defined.